Forest Pursuing Settlement With Alphapharm In Lexapro Patent Infringement Case
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest stresses that negotiations do not affect ongoing litigation with Ivax and Cipla over the same patent.
You may also be interested in...
Ivax Will Not Settle Lexapro Patent Challenge
Ivax denies speculation that it is in discussions with Forest to settle patent litigation regarding Forest's antidepressant Lexapro (escitalopram)
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.